Medication info

Dopramine Injection (Dopamine Hydrochloride)

Prescription medicationInjectionsIntravenous injection
Ingredient · strength
Dopamine Hydrochloride›40mg / 1mL
Manufacturer / importer
Ilyun Pharmaceutical Co., Ltd.
Appearance
A transparent liquid that is colorless to light yellow, packaged in brown transparent ampoules as an injectable solution
Packaging
5mL/ampoule × 50
Approval status
Active

MFDS item code 197800042 · Notified 1978.09.01 · Insurance code 658600131

Summary

Main use
Improvement of shock, hypotension due to decreased cardiac output, and decreased urine output (oliguria, anuria)
Who receives it
Adults
Adult administration
Adults: Administer dopamine hydrochloride by intravenous injection at 2-5㎍/min per ㎏ of body weight. In severe cases, the dose may be increased from 5-10㎍/min per ㎏ of body weight up to 20-50㎍/min per ㎏ of body weight. The dose may be adjusted as appropriate according to age and symptoms. Before administering this medicine, administer blood or plasma to achieve a venous pressure of 10-15㎝ H2O and a pulmonary capillary wedge pressure of 14-18mmHg. When administering 50㎍/min per ㎏ of body weight or more, check urine output frequently. For intravenous injection, dilute in 250㎖ or 500㎖ of one of the following solutions: normal saline for injection, 5% dextrose injection, 5% dextrose in 0.9% normal saline injection, 5% dextrose dissolved in 0.45% normal saline injection, 5% dextrose dissolved in lactated Ringer's solution, sodium lactate injection, lactated Ringer's solution, etc.

Ingredients

Manufacturer
Ilyun Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of shock, hypotension due to decreased cardiac output, and decreased urine output (oliguria, anuria)

  • Myocardial infarction
  • trauma
  • toxic shock syndrome
  • postoperative shock
  • renal shock
  • shock due to chronic heart failure
  • oliguria
  • anuria
  • hypotension due to decreased cardiac output
View approved original text

This medication is used to treat shock symptoms due to serious conditions such as myocardial infarction, trauma, and toxic shock syndrome, as well as kidney function decline after surgery and chronic heart failure. It is also effectively used for hypotension due to decreased urine output and anuria. It helps restore circulation and blood pressure and stabilizes bodily functions in these various situations. Therefore, it plays a critical role in improving heart and kidney health in patients.

How it is given

Adult administration

Adults: Administer dopamine hydrochloride by intravenous injection at 2-5㎍/min per ㎏ of body weight. In severe cases, the dose may be increased from 5-10㎍/min per ㎏ of body weight up to 20-50㎍/min per ㎏ of body weight. The dose may be adjusted as appropriate according to age and symptoms. Before administering this medicine, administer blood or plasma to achieve a venous pressure of 10-15㎝ H2O and a pulmonary capillary wedge pressure of 14-18mmHg. When administering 50㎍/min per ㎏ of body weight or more, check urine output frequently. For intravenous injection, dilute in 250㎖ or 500㎖ of one of the following solutions: normal saline for injection, 5% dextrose injection, 5% dextrose in 0.9% normal saline injection, 5% dextrose dissolved in 0.45% normal saline injection, 5% dextrose dissolved in lactated Ringer's solution, sodium lactate injection, lactated Ringer's solution, etc.

Precautions

When using this medication, be careful to cut the ampoule to minimize the risk of glass fragments entering it. Extra caution is required when using it for children or the elderly. This medication should not be used in patients with certain conditions. For example, it should not be administered to patients with pheochromocytoma, tachyarrhythmias, ventricular fibrillation, hyperthyroidism, or angle-closure glaucoma. Patients with peripheral vascular disorders or allergies to sulfites should use this medication with caution. People sensitive to sulfites may experience allergic reactions such as asthma attacks, so attention is needed. This medication may cause cardiac-related side effects, so heart rhythm abnormalities and blood pressure changes should be carefully monitored. If peripheral blood vessels constrict, causing cold or discolored hands and feet, administration should be stopped and appropriate treatment must be taken. Gastrointestinal symptoms such as nausea, vomiting, and abdominal pain may occur, and in rare cases, serious problems such as intestinal obstruction may arise. Headaches or anxiety may occur, and there is a possibility of inflammation or tissue damage at the injection site. When administering this medication, sufficient consideration should be given to the patient's blood volume and heart function status, and if needed, fluid or blood supplementation and respiratory management should be performed alongside. If the pulse suddenly slows, the dosage should be reduced, and the patient should be observed closely while monitoring blood pressure and urine output attentively. Care should be taken regarding interactions when using with other medications. Specifically, when combined with certain anesthetics, antidepressants, or drugs affecting the sympathetic nervous system, it may cause cardiac stimulation or blood pressure changes, so caution is warranted. Women who are pregnant or may become pregnant should only use this medication when the therapeutic benefits are considered to outweigh the risks, and during breastfeeding, administration should be avoided if possible or breastfeeding should be discontinued. Safety and efficacy have not been established for pediatric patients, so use should be avoided. Elderly patients may experience side effects more easily due to decreased body function, so it is essential to start with a lower dose and carefully monitor their condition during administration. If the medication leaks at the injection site, tissue necrosis may occur, so it is essential to administer it into a large vein and closely observe the condition of the injection site. This medication may lose effectiveness if mixed with alkaline solutions, so it should not be mixed with alkaline solutions, and after dilution, it should be used within 24 hours.

Side effects

  • Ventricular extrasystole
  • atrial fibrillation
  • ventricular tachycardia
  • peripheral vascular contraction
  • tachycardia
  • angina pectoris
  • palpitations
  • dyspnea
  • hypotension
  • abnormal conduction
Show 14 more
  • bradycardia
  • prolonged QRS duration
  • hypernitrogenemia
  • increased blood pressure
  • nausea
  • vomiting
  • abdominal distension
  • abdominal pain
  • paralytic ileus
  • headache
  • anxiety
  • venous thrombophlebitis
  • injection site necrosis
  • tongue swelling

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to light, so it should be stored in a sealed container that does not allow light in. Additionally, when storing the medication, it is crucial to maintain a room temperature between 1 degree and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness and safety.

Appearance and packaging

Appearance

A transparent liquid that is colorless to light yellow, packaged in brown transparent ampoules as an injectable solution

Package unit

5mL/ampoule × 50

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.